He was granted a research fellowship on gene therapy for prostate cancer by the Dutch Cancer Society, and spent a two year period at Baylor College of Medicine, Houston, USA, with Prof Timothy Thompson and Peter Scardino, and afterwards at the oncology lab of Prof. Bob Pinedo at the Free University in Amsterdam. Chris Bangma participated in the European Fifth Framework Program from 2000 onwards on the preclinical development of gene therapeutic vectors, followed by coordinating the clinical application in the GIANT consortium within the European Sixth Framework Program. He has participated to the European Randomised study on Screening of Prostate Cancer ERSPC from its start in 1992, and has coordinated the P-Mark consortium since 2004 till 2008 under the umbrella of the Sixth Framework Program for the search and validation of prognostic serum markers for prostate cancer. Furthermore, he is • PI of the PRIAS (Prostate Cancer International Study of Active Surveillance) since 2006 • PI of PROCABIO (Prostate Cancer Biomarker research in clinical setting of Active Surveillance, a European initiative to develop tailored treatment of prostate cancer by biomarkers), • PI of ZonMw Translationeel Gentherapeutisch Onderzoek (Oncolytic adenovirus therapy as a neoadjuvant treatment for prostate cancer), • co-investigator on PRO-NEST (Prostate Research Organizations-Network of Early Stage Training, 7th Framework EC, Peoples Program), • PI on PCMM (Prostate Cancer Molecular Medicine, the Dutch integrated academia – industry program) programs/studies since 2010 PI of Global Action Plan 3 of Movember on active surveillance for Pca • PI of Pearl 12 Urogenital tumours within String of Pearls( = Parelsnoer, an academic biobanking Current research interest: - Development of prognostic markers for prostate and bladder cancer - Genetherapeutic approaches - Early detection and management of prostate cancer Chris Bangma is member of various scientific societies, of which: the American Urological Association (AUA) , the European Society for Urological Research (ESUR), the American Association of Genito-Urinary Surgeons (AAGUS) as of May, 1st, 2008, the Association of Academic European Urologists (AAEU), and the scientific committee EAU since 2012. Bangma has been President of the Dutch Association of Urology, 2009-2012. Currently within Erasmus MC he is Chairman of devision of Gynaecology, Obstetrics and Urology, Erasmus MC, Rotterdam. Chris has contributed to over 200 papers on prostate and bladder cancer as an author or co-author.